SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021179
Filing Date
2023-05-11
Accepted
2023-05-11 16:01:20
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q meip-20230331.htm   iXBRL 10-Q 1981989
2 EX-31.1 meip-ex31_1.htm EX-31.1 19902
3 EX-31.2 meip-ex31_2.htm EX-31.2 19737
4 EX-32.1 meip-ex32_1.htm EX-32.1 14455
5 GRAPHIC img104057454_0.jpg GRAPHIC 18202
  Complete submission text file 0000950170-23-021179.txt   8073567

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT meip-20230331_pre.xml EX-101.PRE 325702
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT meip-20230331.xsd EX-101.SCH 48458
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT meip-20230331_cal.xml EX-101.CAL 37600
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT meip-20230331_def.xml EX-101.DEF 257642
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT meip-20230331_lab.xml EX-101.LAB 434514
55 EXTRACTED XBRL INSTANCE DOCUMENT meip-20230331_htm.xml XML 1641824
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 23910766
SIC: 2834 Pharmaceutical Preparations